Record ID | harvard_bibliographic_metadata/ab.bib.10.20150123.full.mrc:125417496:1766 |
Source | harvard_bibliographic_metadata |
Download Link | /show-records/harvard_bibliographic_metadata/ab.bib.10.20150123.full.mrc:125417496:1766?format=raw |
LEADER: 01766cam a22003014a 4500
001 010174129-4
005 20070427100457.0
008 060518s2006 maua b 001 0 eng
010 $a 2006016541
020 $a1591398401
020 $a9781591398400
024 3 $a9781591398400
035 0 $aocm69028267
040 $aDLC$cDLC$dBAKER$dC#P$dYDX
042 $apcc
050 00 $aHD9999.B442$bP57 2006
082 00 $a338.4/76606$222
100 1 $aPisano, Gary P.
245 10 $aScience business :$bthe promise, the reality, and the future of biotech /$cGary P. Pisano.
260 $aBoston, Mass. :$bHarvard Business School Press,$cc2006.
300 $axvi, 237 p. :$bill. ;$c25 cm.
504 $aIncludes bibliographical references (p. 213-221) and index.
505 0 $aThe science-based business : a novel experiment -- Mapping the scientific landscape -- The complex anatomy of drug R&D -- Drug R&D and the organizational challenges -- The anatomy of a science-based business -- The performance of the biotech industry : promise versus reality -- The monetization of intellectual property -- Organizational strategies and business models -- The path ahead.
520 1 $a"Why has the biotechnology industry fallen so short of expectations - despite its grand promise? In Science Business, Gary Pisano answers this question by providing an incisive critique of the industry. Pisano not only reveals biotech's most daunting challenges, he offers the most sophisticated analysis yet of how the industry works. And he provides clear prescriptions for companies, investors, and policymakers seeking ways to improve the industry's performance."--Jacket.
650 0 $aBiotechnology industries$xHistory.
655 7 $aHistory.$2fast
988 $a20061212
906 $0DLC